FMED holdings
All 70 positions of Fidelity Disruptive Medicine ETF.
Positions
70
Top 10 weight
31.4%
Effective holdings
48.9
1 / sum of squared weights
In stocks
99.7%
In bonds
0.0%
Outside the US
22.1%
Asset mix
Sectors
86% of stocks classifiedCountries
Holdings
| # | Holding | Type | Weight | Value | Shares / par | Country |
|---|---|---|---|---|---|---|
| 1 | Fidelity Revere Street Trust | Cash | 10.27% | $4.2M | 4,206,098 | US |
| 2 | UCB SA | Equity | 4.73% | $1.9M | 6,605 | BE |
| 3 | LFSTLifeStance Health Group, Inc. Common Stock | Equity | 4.27% | $1.8M | 227,100 | US |
| 4 | DHRDanaher Corporation | Equity | 3.42% | $1.4M | 7,675 | US |
| 5 | TXG10x Genomics, Inc. Class A Common Stock | Equity | 3.11% | $1.3M | 45,000 | US |
| 6 | ISRGIntuitive Surgical Inc. | Equity | 2.92% | $1.2M | 2,816 | US |
| 7 | COGTCogent Biosciences, Inc. Common Stock | Equity | 2.85% | $1.2M | 33,428 | US |
| 8 | ALNYAlnylam Pharmaceuticals, Inc. | Equity | 2.79% | $1.1M | 3,791 | US |
| 9 | ARGXargenx SE American Depositary Shares | Equity | 2.78% | $1.1M | 1,365 | NL |
| 10 | LEGNLegend Biotech Corporation American Depositary Shares | Equity | 2.29% | $940K | 34,614 | KY |
| 11 | UNHUNITEDHEALTH GROUP INCORPORATED (Delaware) | Equity | 2.25% | $922K | 2,424 | US |
| 12 | TECHBio-Techne Corp. | Equity | 2.24% | $919K | 17,786 | US |
| 13 | ASCENDIS PHARMA A/S | Equity | 2.11% | $866K | 3,865 | DK |
| 14 | EWEdwards Lifesciences Corp | Equity | 2.11% | $865K | 10,000 | US |
| 15 | MRNAModerna, Inc. Common Stock | Equity | 2.11% | $863K | 18,282 | US |
| 16 | KYMRKymera Therapeutics, Inc. Common Stock | Equity | 1.99% | $814K | 10,000 | US |
| 17 | XENEXenon Pharmaceuticals Inc | Equity | 1.92% | $786K | 14,366 | CA |
| 18 | HTFLHeartflow, Inc. Common Stock | Equity | 1.89% | $774K | 24,994 | US |
| 19 | SARTORIUS STEDIM BIOTECH | Equity | 1.84% | $755K | 3,633 | FR |
| 20 | INSMInsmed, Inc. | Equity | 1.79% | $735K | 6,875 | US |
| 21 | VEEVVeeva Systems Inc. | Equity | 1.78% | $730K | 4,188 | US |
| 22 | PCVXVaxcyte, Inc. Common Stock | Equity | 1.77% | $723K | 14,071 | US |
| 23 | RVMDRevolution Medicines, Inc. Common Stock | Equity | 1.73% | $709K | 4,504 | US |
| 24 | CAICaris Life Sciences, Inc. Common Stock | Equity | 1.71% | $702K | 41,991 | US |
| 25 | CRNXCrinetics Pharmaceuticals, Inc. | Equity | 1.65% | $675K | 19,000 | US |
| 26 | AXSMAxsome Therapeutics, Inc | Equity | 1.57% | $645K | 2,752 | US |
| 27 | CYTKCytokinetics Inc. | Equity | 1.55% | $634K | 8,262 | US |
| 28 | VCYTVeracyte, Inc. | Equity | 1.54% | $631K | 13,621 | US |
| 29 | TMOThermo Fisher Scientific, Inc. | Equity | 1.53% | $628K | 1,276 | US |
| 30 | BTSGBrightSpring Health Services, Inc. Common Stock | Equity | 1.53% | $628K | 10,187 | US |
| 31 | PRVAPrivia Health Group, Inc. Common Stock | Equity | 1.48% | $605K | 28,119 | US |
| 32 | BSXBoston Scientific Corp. | Equity | 1.44% | $589K | 12,185 | US |
| 33 | NTRANatera, Inc. Common Stock | Equity | 1.43% | $584K | 2,615 | US |
| 34 | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | Equity | 1.42% | $581K | 12,000 | GB |
| 35 | GHGuardant Health, Inc. Common Stock | Equity | 1.38% | $567K | 4,375 | US |
| 36 | SYKStryker Corporation | Equity | 1.36% | $559K | 1,832 | US |
| 37 | VRDNViridian Therapeutics, Inc. Common Stock | Equity | 1.34% | $548K | 31,100 | US |
| 38 | ALHCAlignment Healthcare, Inc. Common Stock | Equity | 1.25% | $511K | 33,378 | US |
| 39 | LONZA GROUP AG | Equity | 1.22% | $500K | 780 | CH |
| 40 | NUVLNuvalent, Inc. Class A Common Stock | Equity | 1.21% | $497K | 4,504 | US |
| 41 | STOKStoke Therapeutics, Inc. Common Stock | Equity | 1.18% | $484K | 15,670 | US |
| 42 | IRONDisc Medicine, Inc. Common Stock | Equity | 1.18% | $482K | 6,926 | US |
| 43 | DXCMDexCom, Inc. | Equity | 1.18% | $482K | 6,533 | US |
| 44 | PODDInsulet Corporation | Equity | 1.10% | $451K | 3,112 | US |
| 45 | LLYEli Lilly & Co. | Equity | 1.07% | $436K | 395 | US |
| 46 | ELVNEnliven Therapeutics, Inc. Common Stock | Equity | 1.03% | $424K | 10,703 | US |
| 47 | CTMXCytomX Therapeutics, Inc. | Equity | 0.98% | $403K | 112,069 | US |
| 48 | WAYWaystar Holding Corp. Common Stock | Equity | 0.98% | $402K | 20,187 | US |
| 49 | IRTCiRhythm Holdings, Inc. Common Stock | Equity | 0.96% | $395K | 3,471 | US |
| 50 | KESTRA MEDICAL TECHNOLOGIES INC | Equity | 0.95% | $391K | 18,400 | BM |
| 51 | NEWAMSTERDAM PHARMA COMPANY NV | Equity | 0.91% | $375K | 11,122 | NL |
| 52 | AMLXAmylyx Pharmaceuticals, Inc. Common Stock | Equity | 0.82% | $338K | 23,554 | US |
| 53 | ROIVANT SCIENCES LTD | Equity | 0.82% | $337K | 11,250 | BM |
| 54 | ALGNAlign Technology Inc | Equity | 0.80% | $326K | 1,863 | US |
| 55 | RGENRepligen Corp | Equity | 0.75% | $308K | 2,485 | US |
| 56 | ZLABZai Lab Limited American Depositary Shares | Equity | 0.66% | $270K | 15,273 | KY |
| 57 | MIRMMirum Pharmaceuticals, Inc. Common Stock | Equity | 0.54% | $222K | 2,191 | US |
| 58 | UPBUpstream Bio, Inc. Common Stock | Equity | 0.51% | $208K | 24,900 | US |
| 59 | RLAYRelay Therapeutics, Inc. Common Stock | Equity | 0.45% | $183K | 12,996 | US |
| 60 | GPCRStructure Therapeutics Inc. American Depositary Shares | Equity | 0.44% | $182K | 4,628 | KY |
| 61 | ZBIOZenas BioPharma, Inc. Common Stock | Equity | 0.44% | $181K | 9,817 | US |
| 62 | VKTXViking Therapeutics, Inc | Equity | 0.43% | $178K | 5,422 | US |
| 63 | PRCTPROCEPT BioRobotics Corporation Common Stock | Equity | 0.43% | $175K | 6,656 | US |
| 64 | JANXJanux Therapeutics, Inc. Common Stock | Equity | 0.42% | $171K | 11,754 | US |
| 65 | OMOutset Medical, Inc. Common Stock | Equity | 0.41% | $166K | 34,000 | US |
| 66 | MBXMBX Biosciences, Inc. Common Stock | Equity | 0.39% | $161K | 5,128 | US |
| 67 | OLMAOlema Pharmaceuticals, Inc. Common Stock | Equity | 0.36% | $148K | 11,250 | US |
| 68 | Fidelity Revere Street Trust | Cash | 0.29% | $119K | 118,650 | US |
| 69 | ORKAOruka Therapeutics, Inc. Common Stock | Equity | 0.14% | $59K | 1,000 | US |
| 70 | SYRESpyre Therapeutics, Inc. Common Stock | Equity | 0.05% | $22K | 300 | US |
Find which other funds hold a stock by opening it and choosing "ETFs holding".
Position changes between reports
| Action | Holding | Weight before | Weight after | Shares vs flows | Between reports |
|---|---|---|---|---|---|
| Decrease | BSXBOSTON SCIENTIFIC CORP | 4.04% | 1.44% | −39.1% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | ASCENDIS PHARMA A/S | — | 2.11% | — | Feb 28, 2026 → May 31, 2026 SEC |
| New position | HTFLHEARTFLOW INC | — | 1.89% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | LFSTLIFESTANCE HEALTH GROUP INC | 2.46% | 4.27% | +75.6% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | RVMDREVOLUTION MEDICINES INC | — | 1.73% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | PENPENUMBRA INC | 1.70% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| New position | AXSMAXSOME THERAPEUTICS INC | — | 1.57% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | WAYWAYSTAR HOLDING CORP | 2.53% | 0.98% | −46.2% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | BTSGBRIGHTSPRING HEALTH SERVICES INC | — | 1.53% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | ASNDASCENDIS PHARMA A/S | 1.48% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | PODDINSULET CORP | 2.58% | 1.10% | −21.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | TECHBIO TECHNE CORP | 0.81% | 2.24% | +240.3% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | TXG10X GENOMICS INC | 1.70% | 3.11% | +59.9% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | VRDNVIRIDIAN THERAPEUTICS INC | — | 1.34% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | VEEVVEEVA SYS INC | 2.99% | 1.78% | −33.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | RMDRESMED INC | 1.18% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | ARGXARGENX SE | 3.84% | 2.78% | −28.5% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | CNTACENTESSA PHARMACEUTICALS PLC | 1.00% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | COGTCOGENT BIOSCIENCES INC | 3.83% | 2.85% | −10.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | WAVE LIFE SCIENCES LTD | 0.91% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | UNHUNITEDHEALTH GROUP INC | 1.43% | 2.25% | +30.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | XENEXENON PHARMACEUTICALS INC | 1.11% | 1.92% | +46.7% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | LLYELI LILLY and CO | 1.78% | 1.07% | −38.7% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | UCB SA | 4.06% | 4.73% | +27.3% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | DOCSDOXIMITY INC | 0.64% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | KINIKSA PHARMACEUTICALS INTERNATIONAL PLC | 0.88% | 1.42% | +59.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | KYMRKYMERA THERAPEUTICS INC | 1.50% | 1.99% | +59.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | GHGUARDANT HEALTH INC | 0.92% | 1.38% | +16.6% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | RLAYRELAY THERAPEUTICS INC | — | 0.45% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | BNTXBIONTECH SE | 0.42% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| New position | MBXMBX BIOSCIENCES INC | — | 0.39% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | CAICARIS LIFE SCIENCES INC | 1.32% | 1.71% | +67.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Exit | SLNOSOLENO THERAPEUTICS INC | 0.39% | — | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | CRNXCRINETICS PHARMACEUTICALS INC | 1.28% | 1.65% | +59.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Decrease | VKTXVIKING THERAPEUTICS INC | 0.74% | 0.43% | −35.2% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | UPBUPSTREAM BIO INC | 0.20% | 0.51% | +148.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | ALHCALIGNMENT HEALTHCARE INC | 0.95% | 1.25% | +77.4% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | NEWAMSTERDAM PHARMA COMPANY NV | 0.63% | 0.91% | +64.8% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | IRTCIRHYTHM TECHNOLOGIES INC | 0.69% | 0.96% | +76.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | KESTRA MEDICAL TECHNOLOGIES INC | 0.70% | 0.95% | +59.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | AMLXAMYLYX PHARMACEUTICALS INC | 0.59% | 0.82% | +59.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | ISRGINTUITIVE SURGICAL INC | 3.14% | 2.92% | +18.5% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | OMOUTSET MEDICAL INC | 0.19% | 0.41% | +59.9% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | NUVLNUVALENT INC | 1.00% | 1.21% | +20.1% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | INSMINSMED INC | 1.96% | 1.79% | +37.5% | Feb 28, 2026 → May 31, 2026 SEC |
| New position | ORKAORUKA THERAPEUTICS INC | — | 0.14% | — | Feb 28, 2026 → May 31, 2026 SEC |
| New position | SYRESPYRE THERAPEUTICS INC | — | 0.05% | — | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | ZBIOZENAS BIOPHARMA INC | 0.43% | 0.44% | +57.0% | Feb 28, 2026 → May 31, 2026 SEC |
| Increase | CTMXCYTOMX THERAPEUTICS INC | 0.99% | 0.98% | +59.9% | Feb 28, 2026 → May 31, 2026 SEC |
Share-count changes are measured after removing what creations and redemptions explain.
Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.